104 related articles for article (PubMed ID: 18704418)
1. Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high p15INK4b gene methylation and high global DNA methylation.
Lehmann U; Dobbelstein C; Fenner M; Römermann D; Hasemeier B; Metzig K; Steinemann D; Büsche G; Krauter J; Ganser A; Kreipe H
Ann Hematol; 2009 Mar; 88(3):275-7. PubMed ID: 18704418
[No Abstract] [Full Text] [Related]
2. Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.
Song LX; Xu L; Li X; Chang CK; Zhang Y; Wu LY; He Q; Zhang QX; Li X
Ann Hematol; 2012 Dec; 91(12):1879-86. PubMed ID: 22895556
[TBL] [Abstract][Full Text] [Related]
3. Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition.
Lakshmikuttyamma A; Scott SA; DeCoteau JF; Geyer CR
Oncogene; 2010 Jan; 29(4):576-88. PubMed ID: 19881540
[TBL] [Abstract][Full Text] [Related]
4. Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia.
Claus R; Pfeifer D; Almstedt M; Zucknick M; Hackanson B; Plass C; Lübbert M
Leuk Res; 2013 Feb; 37(2):190-6. PubMed ID: 23158571
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies.
Hackanson B; Robbel C; Wijermans P; Lübbert M
Ann Hematol; 2005 Dec; 84 Suppl 1():32-8. PubMed ID: 16292549
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia.
Yang AS; Doshi KD; Choi SW; Mason JB; Mannari RK; Gharybian V; Luna R; Rashid A; Shen L; Estecio MR; Kantarjian HM; Garcia-Manero G; Issa JP
Cancer Res; 2006 May; 66(10):5495-503. PubMed ID: 16707479
[TBL] [Abstract][Full Text] [Related]
7. [Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].
Ye XS; Liu T; Cui X; Meng WT; Xi YM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):57-9. PubMed ID: 17294728
[TBL] [Abstract][Full Text] [Related]
8. Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.
Deneberg S; Grövdal M; Karimi M; Jansson M; Nahi H; Corbacioglu A; Gaidzik V; Döhner K; Paul C; Ekström TJ; Hellström-Lindberg E; Lehmann S
Leukemia; 2010 May; 24(5):932-41. PubMed ID: 20237504
[TBL] [Abstract][Full Text] [Related]
9. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
[TBL] [Abstract][Full Text] [Related]
10. Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML.
Paul TA; Bies J; Small D; Wolff L
Blood; 2010 Apr; 115(15):3098-108. PubMed ID: 20190193
[TBL] [Abstract][Full Text] [Related]
11. A selective activity of DNMTi decitabine on AML1ETO positive cells?
Santini V
Leuk Res; 2007 Jun; 31(6):741-2. PubMed ID: 17240447
[No Abstract] [Full Text] [Related]
12. P15INK4b gene methylation and myelodysplastic syndromes.
Quesnel B; Fenaux P
Leuk Lymphoma; 1999 Nov; 35(5-6):437-43. PubMed ID: 10609781
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.
Fabiani E; Leone G; Giachelia M; D'alo' F; Greco M; Criscuolo M; Guidi F; Rutella S; Hohaus S; Voso MT
Leuk Lymphoma; 2010 Dec; 51(12):2275-84. PubMed ID: 21077739
[TBL] [Abstract][Full Text] [Related]
14. Impact of Global and Gene-Specific DNA Methylation in de Novo or Relapsed Acute Myeloid Leukemia Patients Treated with Decitabine.
Zhang LY; Yuan YQ; Zhou DM; Wang ZY; Ju SG; Sun Y; Li J; Fu JX
Asian Pac J Cancer Prev; 2016; 17(1):431-7. PubMed ID: 26838251
[TBL] [Abstract][Full Text] [Related]
15. The role of hypomethylating agents in the treatment of elderly patients with AML.
Al-Ali HK; Jaekel N; Niederwieser D
J Geriatr Oncol; 2014 Jan; 5(1):89-105. PubMed ID: 24484723
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice.
Wolff L; Garin MT; Koller R; Bies J; Liao W; Malumbres M; Tessarollo L; Powell D; Perella C
Oncogene; 2003 Dec; 22(58):9265-74. PubMed ID: 14681685
[TBL] [Abstract][Full Text] [Related]
17. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia.
Shimamoto T; Ohyashiki JH; Ohyashiki K
Leuk Res; 2005 Jun; 29(6):653-9. PubMed ID: 15863205
[TBL] [Abstract][Full Text] [Related]
18. [Expression and methylation of CpG islands in the promoter of p15INK4B gene in children with acute myeloid leukemia].
Wen FQ; Chen YX; Cao LZ
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):207-8. PubMed ID: 15833197
[No Abstract] [Full Text] [Related]
19. Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5.
Hur EH; Jung SH; Goo BK; Moon J; Choi Y; Choi DR; Chung YJ; Lee JH
Oncotarget; 2017 Feb; 8(7):11748-11762. PubMed ID: 28052028
[TBL] [Abstract][Full Text] [Related]
20. The role of decitabine for the treatment of acute myeloid leukemia.
Ganetsky A
Ann Pharmacother; 2012 Nov; 46(11):1511-7. PubMed ID: 23115225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]